EBOS Group Limited
Research EBOS Group Limited (EBO.AX) on Bullrun: market cap AUD 3.47B, P/E 14.3, dividend yield 5.2%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerEBO.AX
- ExchangeAU
- CountryAustralia
- SectorHealthcare
- IndustryMedical Distribution
- CurrencyAUD
- Market capAUD 3.47B
- P/E14.3
- Dividend yield5.2%
- Financial periodFY2026
- RevenueNZD 16.41B
- Revenue growth24.2%
- Net incomeNZD 273.95M
- Free cash flowNZD 336.09M
- Gross margin12.9%
Valuation Snapshot
latest market cap is AUD 3.47B; P/E is 14.3; dividend yield is 5.2%.
Peer valuation comparison
Latest P/E is 14.3x versus a Healthcare sector median of 21.74x (34.2% below).
Latest dividend yield is 5.18% versus a Healthcare sector median of 2.4% (115.8% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2026 | NZD 16.41B | NZD 273.95M | NZD 336.09M | 12.9% | 1.33 | NZD 290.86M | NZD 2.31B | NZD 3.34B |
| FY2025 | NZD 13.21B | NZD 231.66M | NZD 396.38M | 13.3% | 1.17 | NZD 198.40M | NZD 1.75B | NZD 2.95B |
| FY2024 | NZD 14.41B | NZD 296.71M | NZD 288.18M | 12.4% | 1.54 | NZD 236.98M | NZD 1.80B | NZD 2.68B |
| FY2023 | NZD 13.32B | NZD 275.74M | NZD 318.89M | 12.8% | 1.45 | NZD 230.59M | NZD 1.40B | NZD 2.65B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-17 | AUD 3.47B | 14.3 | 5.2% | 0.86 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.86 AUD, yield 5.2%.
| Year | Dividends/share |
|---|---|
| FY2026 | 0.86 NZD |
| FY2025 | 0.95 NZD |
| FY2024 | 0.97 NZD |
| FY2023 | 0.9 NZD |
| FY2022 | 0.77 NZD |
About EBOS Group Limited
EBOS Group Limited engages in the marketing, wholesale, and distribution of healthcare, medical, pharmaceutical, and animal care products in Australia, Southeast Asia, and New Zealand. It operates through the Healthcare and Animal Care segments. The company provides healthcare logistics; medication management solutions; pharmacy management software; pharmacy data, consumer loyalty, and analytics services; and health communications, programs, and consultancy services.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is EBOS Group Limited's market cap?
EBOS Group Limited's market capitalization is AUD 3.47B.
What is EBOS Group Limited's P/E ratio?
EBOS Group Limited's price-to-earnings (P/E) ratio is 14.3.
Does EBOS Group Limited pay a dividend?
EBOS Group Limited has a dividend yield of 5.2%.
What does EBOS Group Limited do?
EBOS Group Limited engages in the marketing, wholesale, and distribution of healthcare, medical, pharmaceutical, and animal care products in Australia, Southeast Asia, and New Zealand. It operates through the Healthcare and Animal Care segments. The company provides healthcare logistics; medication management solutions; pharmacy management software; pharmacy data, consumer loyalty, and analytics services; and health communications, programs, and consultancy services.